— Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) reported a loss of $0.08 per share in the fourth quarter of 2019, in line with Wall Street expectation.
— Q4 revenue was flat at $1.2 million, vs. $920,000 expected.
— As at December 31, 2019, Titan had cash and cash equivalents of approximately $5.2 million.
— Launch of Sixmo may be delayed due to the impact of Covid-19.
— TTNP shares gained 4.4% during after-market trading hours.
Most Popular
Earnings Preview: Costco (COST) looks poised to end fiscal 2024 on a high note
Costco Wholesale Corporation (NASDAQ: COST), which operates a chain of membership warehouses, will unveil its fourth-quarter results on the evening of September 26. It has a good track record of
Key takeaways from General Mills’ (GIS) Q1 2025 earnings report
Shares of General Mills, Inc. (NYSE: GIS) gained over 1% on Wednesday after the company’s announcement of its first quarter 2025 earnings results. Revenue came in line with estimates while
GIS Earnings: All you need to know about General Mills’ Q1 2025 earnings results
General Mills, Inc. (NYSE: GIS) reported its first quarter 2025 earnings results today. Net sales decreased 1% year-over-year to $4.8 billion. Organic sales were down 1%. Net earnings attributable to
